Effects of minimal-dose aprotinin on coronary artery bypass grafting
- 31 August 1997
- journal article
- clinical trial
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 114 (2) , 261-269
- https://doi.org/10.1016/s0022-5223(97)70154-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Half-dose aprotinin preserves hemostatic function in patients undergoing bypass operationsThe Annals of Thoracic Surgery, 1995
- Reporting the results of blood conservation studies: The need for uniform and comprehensive methodsThe Annals of Thoracic Surgery, 1994
- Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery.Circulation, 1994
- Renal dysfunction and intravascular coagulation with aprotinin and hypothermic circulatory arrestThe Annals of Thoracic Surgery, 1993
- Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypassThe Annals of Thoracic Surgery, 1993
- Aprotinin in perspectiveThe Annals of Thoracic Surgery, 1993
- Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled studyThe Annals of Thoracic Surgery, 1992
- Effects of Aprotinin on Hemostatic Mechanisms during Cardiopulmonary BypassThe Annals of Thoracic Surgery, 1987
- EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERYThe Lancet, 1987
- Methods for semi micro or automated determination of thrombin, antithrombin, and heparin cofactor using the substrate, · 2HC1Clinica Chimica Acta; International Journal of Clinical Chemistry, 1977